Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19. | Lancet;396(10259): e61-e62, 2020 10 24. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.

Carlet, Jean; Payen, Didier; Opal, Steven M.

Affiliation

Carlet J; World Alliance Against Antibiotic Resistance, 94000 Créteil, France. Electronic address: jeancarlet@gmail.com.
Payen D; Paris 7 University, Paris, France.
Opal SM; Infectious Disease Division, Alpert Medical School of Brown University, Providence, RI, USA.

Lancet ; 396(10259): e61-e62, 2020 10 24.

Article in En | MEDLINE | ID: mdl-33045189

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / Sepsis / COVID-19 Limits: Humans Language: En Journal: Lancet Year: 2020 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / Sepsis / COVID-19 Limits: Humans Language: En Journal: Lancet Year: 2020 Document type: Article